Neuroventi is a bioventure focused on developing new treatments for developmental disorders, providing unparalleled expertise in preclinical CDRO services specialized in CNS disorders. Drawing on our experience in neuroscience research and drug development, we provide a one-stop service from early discovery to candidate selection, including the identification of therapeutic candidates for CNS disorders(neurological, psychiatric, and n), preclinical research consulting, and evaluation of preclinical efficacy and safety for candidate.
We provide research services for the discovery and development of new drug candidates, including small molecules, natural extracts, microbial strains, microbiome-related substances, exosomes, and cell therapies, as well as functional food candidates. Our goal is to achieve the best research outcomes by establishing optimal research plans tailored to client needs, selecting appropriate models, and defining preliminary experiment and evaluation methods.